Skip to content
Stop using now Drug recall · FDA · Published October 30, 2014

Baxter Recalls Heparin Sodium Injection Due to Low Potency

Baxter Healthcare recalls specific lots of Heparin Sodium in 0.9% Sodium Chloride Injection due to subpotent raw material. Check your lot numbers immediately.

🇺🇸 FDA recall #D-0276-2015DrugBaxter Healthcare ›
Take action

Contact the company

Recalling firmBaxter Healthcare Corp.1 Baxter Pkwy · Deerfield, IL 60015-4625
✎ GovInfoNow plain-language explainer

Baxter Healthcare Corporation is recalling Heparin Sodium in 0.9% Sodium Chloride Injection because the raw material was found to have low potency, making the drug subpotent. The recall affects 127,746 Viaflex Plus Containers distributed nationwide. These units were manufactured at the Jayuya, Puerto Rico facility and had an expiration date of February 29, 2016. Read more at govinfonow.com/recall/45642-baxter-healthcare-corp-recalls-heparin-sodium-in-0-9-sodium.

Source Summary by GovInfoNow · govinfonow.com/recall/45642-baxter-healthcare-corp-recalls-heparin-sodium-in-0-9-sodium · Updated October 12, 2026 · FDA enforcement record: FDA #D-0276-2015

Cite this page

“Baxter Recalls Heparin Sodium Injection Due to Low Potency.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45642-baxter-healthcare-corp-recalls-heparin-sodium-in-0-9-sodium. Based on FDA recall #D-0276-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0276-2015%22&limit=1).

The FDA announced on Oct. 30, 2014, that Baxter Healthcare Corp. recalled Heparin Sodium in 0.9% Sodium Chloride Injection due to subpotent drug concerns. The agency stated the recall was voluntary and initiated by the firm.

How to tell if you have it

  • Brand: Baxter Healthcare
  • Product: Heparin Sodium Injection
  • NDC: 0338-0431-03
  • Lot codes: N003061, N003079, and N003087
  • Expiration date: 2/29/2016
  • Quantity: 127,746 Viaflex Plus Containers

The hazard

The recall addresses a subpotent drug hazard where Heparin raw material was found to have low potency. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Baxter Healthcare Corp. has 34 other recalls on record since Sept. 21, 2012. Other recent recalls of similar products include the Baxter Amia Dialysis Set Recall (Sept. 1, 2017), the Baxter Recalls Brevibloc Injection Due to Discoloration (April 12, 2016), and the Baxter Recalls Sodium Chloride Irrigation Due to Insect Contamination (Feb. 5, 2016). Additional recent recalls of similar products include the Baxter Famotidine Injection Recall (Aug. 6, 2026), the Baxter Vasopressin Injection Recall (Aug. 6, 2026), and the Baxter Pantoprazole Sodium Injection Recall (Aug. 6, 2026).

How to tell if you have this one

Look for Heparin Sodium in 0.9% Sodium Chloride Injection, 1000 USP Heparin Units, 500 mL in a VIAFLEX Plus Container. Check the NDC number (0338-0431-03) and verify if the lot number is N003061, N003079, or N003087.

  • Brand
    Baxter Healthcare
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using the product

    Do not use any Heparin Sodium in 0.9% Sodium Chloride Injection from the recalled lots due to the risk of subpotency.

  2. Check lot numbers

    Verify if your unit has lot numbers N003061, N003079, or N003087 and an expiration date of 2/29/2016.

  3. Contact healthcare provider

    Consult your doctor or pharmacist for guidance on alternative treatment if you have used or possess the recalled product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 23 months after the firm started it.

1. Firm started the recall: Oct 30, 201412. FDA classified it Class II: Nov 24, 201423. Published in FDA’s Enforcement Report: Dec 3, 201434. FDA terminated the recall: Sep 22, 2016420142016
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0276-2015 (October 30, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0276-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA